Content
AYR Wellness' Q1 Financials Reveal 94% Reduction In Net Loss
Article By:
Lorimer Wilson
Read
Wednesday, May 15, 2024 5:06 PM EDT
First quarter results reflect continued progress with modest sequential revenue growth, adjusted EBITDA margins in line with long-term targets of 25% and positive free cash flow for the period.
In this article: AYRWF
All Cresco Labs' QI Financial Metrics Down Except SG&A
Article By:
Lorimer Wilson
Read
Wednesday, May 15, 2024 12:51 PM EDT
Despite the poor Q1 financial report Cresco's stock price is UP 2.5% as of mid-day but is still DOWN 1.9% from last Friday albeit UP 52.6% YTD.
In this article: CRLBF
Current Analysis: Fresenius Medical Care
Article By:
Fredrik Arnold
Read
Wednesday, May 15, 2024 6:15 AM EDT
Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates.
In this article: FMS
Organigram Q2 Financial Metrics Mixed
Article By:
Lorimer Wilson
Read
Tuesday, May 14, 2024 2:00 PM EDT
Of the top 3 licensed producers in Canada Organigram is the only one with significant cash, negligible debt, and sizeable funds earmarked for strategic international investment.
In this article: OGI
J&J: A Healthy Dose Of Income And Growth
Article By:
MoneyShow.com
Read
Tuesday, May 14, 2024 3:30 AM EDT
Johnson & Johnson (JNJ)— founded in 1886 — is a diversified healthcare company and a leader in the area of innovative medicine and medical devices.
In this article: JNJ
2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
Article By:
Zacks Investment Research
Read
Tuesday, May 14, 2024 2:10 AM EDT
Among the medical sector, Alcon and Prestige Consumer Healthcare are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
Current Analysis: Sweden-Based, Elekta AB
Article By:
Fredrik Arnold
Read
Monday, May 13, 2024 9:50 PM EDT
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. Over the past year, Elekta's share price fell about 9.4%.
In this article: EKTAF
Bull Of The Day: Veeva Systems
Article By:
Benjamin Rains
Read
Monday, May 13, 2024 5:21 AM EDT
Veeva’s various cloud software offerings serve vital segments of the economy from pharmaceutical giants to biotech upstarts.
In this article: VEEV
Healthcare And Biotech Investing 101: What You Need To Know.
Article By:
Rod Raynovich
Read
Monday, May 13, 2024 4:44 AM EDT
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of demographics and government funding through Medicare.
Cronos Q1 Financial Metrics Show Improvement; Stock Climbs 3%
Article By:
Lorimer Wilson
Read
Sunday, May 12, 2024 6:39 PM EDT
Cronos Group's stock price was up 25.4% in Q1 (January, February, March), rose 8.8% between then and the release of the Q1 report on May 9th, before slipping by 2.8% the following day. The stock is now up 32.5% YTD.
In this article: CRON
UnitedHealth: A Stock Pick For Healthy Returns
Article By:
MoneyShow.com
Read
Sunday, May 12, 2024 10:45 AM EDT
UNH's share price has an average annual growth rate of 22% over the past 15 years; has increased its annual payout for more than 15 consecutive years; and has almost $33 billion in the bank
In this article: UNH
5 Medical Info Systems Stocks To Buy For Stable Returns
Article By:
Zacks Investment Research
Read
Saturday, May 11, 2024 3:00 PM EDT
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024.
